Baxter International Inc.
COMPOSITIONS AND METHODS FOR DRUG DELIVERY

Abstract:

The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises a surfactant having formula I, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm: ##STR00001##